Purchase Order 75N92E18P00205

<p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $24,200 on January 16, 2019, with ultimate completion on March 11, 2019. Performance occurs at North Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Oxford Nanopore supplies next-generation genomic sequencing instruments, consumables, and reagents to federal research agencies, competing full-and-open across civilian health and research customers.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $24,200 on August 8, 2018, with completion on September 7, 2018. Work is performed in North Bethesda, Maryland. The order procures genomic sequencing instruments, consumables, or reagents consistent with the vendor's core product lines of next-generation sequencing platforms, flow cells, ligation kits, and related laboratory supplies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $50,065.00 on September 7, 2017, for an Oxford Nanopore Starter Pack—a device providing ultra-long read DNA and RNA sequencing using nanopores. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and was scheduled for completion by October 20, 2017.</p>

The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $165,000 on April 18, 2019, with a completion date of July 31, 2019. No set-aside applied. Place of performance is Cambridge, Massachusetts. The order procures next-generation sequencing instruments, consumables, and reagents—specifically PromethION 24 platform equipment and compatible flow cell packs and library preparation reagents for genomic sequencing research. The solicitation was...

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...

<p>The NIH Clinical Center awarded a purchase order to Oxford Nanopore Technologies Inc. for $50,005.00 on September 7, 2018, with completion targeted for September 28, 2018. Performance takes place in Bethesda, Maryland. The order procures next-generation genomic sequencing instruments, consumables, or reagents on a firm fixed-price basis. The originating pre-solicitation was posted July 27, 2018, with bids due August 10, 2018.</p>

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc. for $0.00. The contract has no set-aside designation and calls for delivery of products or services by June 11, 2020 in support of the agency's genome research efforts. As the leading federal funder and coordinator of genome research, this contract likely provides the Institute with nanopore sequencing...

This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the delivery of reagents to assist investigators working to sequence unresolved regions of the human genome. The award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has been awarded several...

The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,508.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of 3 packs of 4 PROMETHION flow cell packs (RNA), with an ultimate completion date of August 7, 2024. This equipment supports NHGRI's ongoing genomics research initiatives, which utilize Oxford...

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $35,000 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a software license and device warranty to support the Oxford Nanopore Promethion 24A sequencing platform. The contract has a period of performance from January 19, 2024 through January 19, 2025. Oxford Nanopore Technologies Inc. will deliver the requested products and services as the prime...